Issue 12/2005
Content (7 Articles)
Regulatory T cells and tumor immunity
Subhasis Chattopadhyay, Nitya G. Chakraborty, Bijay Mukherji
CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype
Javier G. Casado, Rocío Soto, Olga DelaRosa, Esther Peralbo, Maria del Carmen Muñoz-Villanueva, Luis Rioja, José Peña, Rafael Solana, Raquel Tarazona
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation
Wu Peng, Xin Zhang, Nehal Mohamed, Giorgio Inghirami, Kenichi Takeshita, Andrew Pecora, Linda L. Nardone, Steve E. Pincus, Leslie S. Casey, George L. Spitalny
Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: Therapeutic effect against cervical cancer
Zhengrong Cui, Leaf Huang
Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts
Hiroshi Ishiguro, Takashi Kishimoto, Mitsuko Furuya, Yuichiro Nagai, Toru Watanabe, Hiroshi Ishikura
90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas
Angela Coliva, Alberto Zacchetti, Elena Luison, Antonella Tomassetti, Italia Bongarzone, Ettore Seregni, Emilio Bombardieri, Franck Martin, Augusto Giussani, Mariangela Figini, Silvana Canevari
A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells
Sabrina Ottaviani, Yi Zhang, Thierry Boon, Pierre van der Bruggen